Evaluation Of The Pd-1 Inhibitor Cemiplimab In Early-Stage, High-Risk Her2-Negative Breast Cancer: Results From The Neoadjuvant I-Spy 2 Trial
Cemiplimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Evaluation Of The Pd-1 Inhibitor Cemiplimab In Early-Stage, High-Risk Her2-Negative Breast Cancer: Results From The Neoadjuvant I-Spy 2 Trial ### Output: Cemiplimab